Telesis Bio Inc (DNAY) has fallen Friday morning, with the stock losing -3.33% in pre-market trading to 1.45. DNAY's short-term technical score of 60 indicates that the stock has traded more bullishly over the last month than 60% of stocks on the market. In the Medical Devices industry, which ranks 119 out of 146 industries, the stock ranks higher than 70% of stocks. Telesis Bio Inc has fallen 21.47% over the past month, closing at $1.69 on October 28. During this period of time, the stock fell as low as $1.45 and as high as $1.92. DNAY has an average analyst recommendation of Strong Buy. The company has an average price target of $6.50.
DNAY has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on DNAY!